Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Recent evidence suggests that there is a link between metabolic diseases and bacterial populations in the gut. The aim of this study was to assess the differences between the composition of the intestinal microbiota in humans with type 2 diabetes and non-diabetic persons as control. METHODS AND FINDINGS: The study included 36 male adults with a broad range of age and body-mass indices (BMIs), among which 18 subjects were diagnosed with diabetes type 2. The fecal bacterial composition was investigated by real-time quantitative PCR (qPCR) and in a subgroup of subjects (N = 20) by tag-encoded amplicon pyrosequencing of the V4 region of the 16S rRNA gene. The proportions of phylum Firmicutes and class Clostridia were significantly reduced in the diabetic group compared to the control group (P = 0.03). Furthermore, the ratios of Bacteroidetes to Firmicutes as well as the ratios of Bacteroides-Prevotella group to C. coccoides-E. rectale group correlated positively and significantly with plasma glucose concentration (P = 0.04) but not with BMIs. Similarly, class Betaproteobacteria was highly enriched in diabetic compared to non-diabetic persons (P = 0.02) and positively correlated with plasma glucose (P = 0.04). CONCLUSIONS: The results of this study indicate that type 2 diabetes in humans is associated with compositional changes in intestinal microbiota. The level of glucose tolerance should be considered when linking microbiota with metabolic diseases such as obesity and developing strategies to control metabolic diseases by modifying the gut microbiota.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Compelling evidence have shown that the composition of the gut microbiota is altered in animal models of obesity and subjects with prediabetes or type 2 diabetes compared with controls (182–186).”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [183]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Chronic autoimmune inflammatory diseases, including celiac disease,17 type 2 diabetes18 and obesity19 are associated with intestinal dysbiosis.”
From Probiotics and the gut microbiota in intestinal health and disease (2010) · cites this paper as [18]
In the citing paper
“Conversely, heterocyclic amines and glycan derived from red meat may promote inflammation in gut health due to higher concentration of Bacteroides and Fusobacterium and lower levels of Lactobacillus and Roseburia, which are also linked with lower anti-inflammatory responses and increased incidence of type 2 diabetes [191,192,193].”
From Impact of Protein Intake in Older Adults with Sarcopenia and Obesity: A Gut Microbiota Perspective (2020) · cites this paper as [191]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
[RETRACTION]Translational research into gut microbiota: new horizons in obesity treatment
Tsukumo, D. M., Carvalho, B. M., Carvalho-Filho, M. A., & Saad, M. J. A. (2009) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302009000200004 · Cited by 44
RetractedTranslational research into gut microbiota: new horizons in obesity treatment
Tsukumo, D. M. L., Carvalho, B. M., Filho, C., & Saad, M. J. A. (2013) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302013000900014 · Cited by 17
RetractedAn obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · cited 1×
“The differences in microbial composition were explained by an increased capacity of the obesity-associated microbiome to harvest energy from the diet [13].”
BackgroundA core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823
The gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245
Obesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176
The Ribosomal Database Project: improved alignments and new tools for rRNA analysis
Cole, J. R., Wang, Q., Cardenas, E., Fish, J., Chai, B., Farris, R. J., Kulam-Syed-Mohideen, A. S., McGarrell, D. M., Marsh, T., Garrity, G. M., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn879 · Cited by 4,762
Inflammation, stress, and diabetes
Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143
Cani, P. D., Possemiers, S., Van de Wiele, T., Guiot, Y., Everard, A., Rottier, O., Geurts, L., Naslain, D., Neyrinck, A., Lambert, D. M., et al. (2009) · Gut · doi:10.1136/gut.2008.165886 · Cited by 2,518 · cited 2×
“For example, levels of Bifidobacterium significantly and positively correlated with improved glucose-tolerance and low-grade inflammation in prebiotic treated-mice [1,6].”
BackgroundMicrobiota and SCFA in lean and overweight healthy subjects
Schwiertz, A., Taras, D., Schäfer, K., Beijer, S., Bos, N. A., Donus, C., & Hardt, P. D. (2010) · Obesity · doi:10.1038/oby.2009.167 · Cited by 2,457
Cited by
Items 701–800 of 1,020
Impact of enrofloxacin on the human intestinal microbiota revealed by comparative molecular analysis
Kim, B. S., Kim, J. N., Yoon, S.-H., Chun, J., & Cerniglia, C. E. (2012) · Anaerobe · doi:10.1016/j.anaerobe.2012.01.003 · Cited by 86
Novel human microbe-disease association prediction using network consistency projection
Bao, W., Jiang, Z., & Huang, D.-S. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1968-2 · Cited by 85
“Compositional changes in intestinal microbiota such as Bacilli , Bacteroidetes , Betaproteobacteria , Clostridia , Clostridium , Firmicutes , Lactobacillus and Proteobacteria were discovered in T2DM patient feces [46].”
BackgroundIntestinal microbial metabolites in human metabolism and type 2 diabetes
Herrema, H., & Niess, J. H. (2020) · Diabetologia · doi:10.1007/s00125-020-05268-4 · Cited by 87
Role of probiotics and prebiotics in mitigation of different diseases
Manzoor, S., Wani, S. M., Ahmad Mir, S., & Rizwan, D. (2022) · Nutrition · doi:10.1016/j.nut.2022.111602 · Cited by 69
Gut-muscle crosstalk. A perspective on influence of microbes on muscle function
Chew, W., Lim, Y. P., Lim, W. S., Chambers, E. S., Frost, G. S., Wong, S. H., & Ali, Y. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2022.1065365 · Cited by 94
Tripolt, N. J., Leber, B., Blattl, D., Eder, M., Wonisch, W., Scharnagl, H., Stojakovic, T., Obermayer-Pietsch, B., Wascher, T. C., Pieber, T. R., et al. (2013) · Journal of Dairy Science · doi:10.3168/jds.2012-5863 · Cited by 80
“Furthermore, Larsen et al. (2010) showed that the intestinal microflora is substantially altered in diabetic compared with healthy individuals, and further studies showed an association of gut microflora with insulin resistance (Creely et al., 2007).”
Shang, H., Sun, J. T., & Chen, Y. Q. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154373 · Cited by 88
Bermingham, E. N., Young, W., Butowski, C. F., Moon, C. D., Maclean, P. H., Rosendale, D., Cave, N., & Thomas, D. G. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01231 · Cited by 87
Probiotics for the treatment of type 2 diabetes: A review of randomized controlled trials
Tiderencel, K. A., Hutcheon, D. A., & Ziegler, J. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3213 · Cited by 82
Time to include the gut microbiota in the hygienic standardisation of laboratory rodents
Bleich, A., & Hansen, A. K. (2012) · Comparative Immunology, Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2011.12.006 · Cited by 82
Jiang, P., Zheng, W., Sun, X., Jiang, G., Wu, S. L., Xu, Y.-X., Song, S., & Ai, C. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.11.116 · Cited by 84
Chains of evidence from correlations to causal molecules in microbiome-linked diseases
Chaudhari, S. N., McCurry, M. D., & Devlin, A. S. (2021) · Nature Chemical Biology · doi:10.1038/s41589-021-00861-z · Cited by 88
Li, L., Han, J., Wu, L., Fang, C., Li, W., Gu, J., Deng, T., Qin, C., Nie, J.-Y., & Zeng, X. (2022) · Military Medical Research · doi:10.1186/s40779-022-00373-4 · Cited by 95
“A previous study has shown that the metabolic diseases of diabetes can significantly reduce Firmicutes and Clostridia in the intestine, and Betaproteobacteria was highly associated with diabetic compared to non-diabetic persons [39].”
BackgroundGarrigues, Q., Apper, E., Chastant‐Maillard, S., & Mila, H. (2022) · Frontiers in Veterinary Science · doi:10.3389/fvets.2022.964649 · Cited by 96
“This imbalance in the gut microbiota, called “dysbiosis,” is implicated not only in many gastro-intestinal diseases such as inflammatory bowel disease or acute diarrhea (107, 108), but also in systemic disorders, such as diabetes in humans (109).”
BackgroundAngelakis, E., Bastelica, D., Amara, A. B., Filali, A. E., Dutour, A., Mège, J., Alessi, M., & Raoult, D. (2011) · Microbial Pathogenesis · doi:10.1016/j.micpath.2011.10.004 · Cited by 86
“[36].”
Gut Dysbiosis and Adaptive Immune Response in Diet-induced Obesity vs. Systemic Inflammation
Pindjakova, J., Sartini, C., Lo Re, O., Rappa, F., Coupe, B., Lelouvier, B., Pazienza, V., & Vinciguerra, M. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01157 · Cited by 81
“Generally, Proteobacteria and Verrucomicrobia are not abundant in the healthy gut, but abundant in the gut dysbiosis of patients with type 2 diabetes or with inflammatory bowel disease (IBD) (Larsen et al., 2010; Qin et al., 2012; Shin et al., 2015).”
BackgroundProteomics, metabolomics and metagenomics for type 2 diabetes and its complications
Wang, N., Zhu, F., Chen, L., & Chen, K. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.09.035 · Cited by 92
Tian, Y., Nichols, R. G., Cai, J., Patterson, A. D., & Cantorna, M. T. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.10.011 · Cited by 82
“Increased Firmicutes to Bacteroidetes ratios are associated with many diseases including diabetes [11].”
BackgroundMorshedi, M., Saghafi‐Asl, M., & Hosseinifard, E.-S. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-019-02169-y · Cited by 86
Potential role of microbiome in Chronic Fatigue Syndrome/Myalgic Encephalomyelits (CFS/ME)
Lupo, G. F. D., Rocchetti, G., Lucini, L., Lorusso, L., Manara, E., Bertelli, M., Puglisi, E., & Capelli, E. (2021) · Scientific Reports · doi:10.1038/s41598-021-86425-6 · Cited by 93
Microorganisms populating the water-related indoor biome
Babič, M. N., Gostinčar, C., & Gunde‐Cimerman, N. (2020) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-020-10719-4 · Cited by 90
The Gut Microbiome in Polycystic Ovary Syndrome and Its Association with Metabolic Traits
Lüll, K., Arffman, R. K., Sola‐Leyva, A., Molina, N. M., Aasmets, O., Herzig, K., Plaza‐Díaz, J., Franks, S., Morin-Papunen, L. C., Tapanainen, J. S., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa848 · Cited by 95
Farsi, Y., Tahvildari, A., Arbabi, M., Vazife, F., Sechi, L. A., Bonjar, A. H. S., Jamshidi, P. K., Nasiri, M. J., & Mirsaeidi, M. S. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.804644 · Cited by 83
Human Microbe-Disease Association Prediction Based on Adaptive Boosting
Peng, L., Yin, J., Zhou, L., Liu, M.-X., & Zhao, Y. F. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02440 · Cited by 86
Bedi, O., Aggarwal, S., Trehanpati, N., Ramakrishna, G., & Krishan, P. (2018) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2018.10.004 · Cited by 85
Probiotics: Protecting Our Health from the Gut
Varela-Trinidad, G. U., Domínguez-Díaz, C., Solórzano-Castanedo, K., Íñiguez-Gutiérrez, L., Hernández-Flores, T. D. J., & Fafutis‐Morris, M. (2022) · Microorganisms · doi:10.3390/microorganisms10071428 · Cited by 85
“For example, a clinical study showed that UA patients had a lower abundance of Bacteroidetes and a higher abundance of Firmicutes than healthy individuals [301].”
BackgroundInfluentialRecent Advances in the Role of Probiotics in Human Inflammation and Gut Health
Rupa, P., & Mine, Y. (2012) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf301903t · Cited by 77
The human microbiome and autoimmunity
Proal, A. D., Albert, P. J., & Marshall, T. G. (2013) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32835cedbf · Cited by 107
“Signi"cant differences can be found in the microbiomes of patients with autoimmune diseases such as diabetes types I [18] and II [19], Crohn’s [20], ulcerative colitis, and psoriasis [21].”
BackgroundDehghan, P., Farhangi, M. A., Tavakoli, F., Aliasgarzadeh, A., & Akbari, A. M. (2015) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2015.12.010 · Cited by 84
Falcinelli, S., Rodiles, A., Hatef, A., Picchietti, S., Cossignani, L., Merrifield, D. L., Unniappan, S., & Carnevali, O. (2018) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001064 · Cited by 79
Role of Bile Acids in Bariatric Surgery
Wang, W., Cheng, Z., Wang, Y., Dai, Y., Zhang, X., & Hu, S. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00374 · Cited by 90
“Larsen et al. found that the proportions of Phylum Firmicutes and Class Clostridia were significantly reduced in T2DM, and Bacteroidetes/Firmicutes ratio was correlated positively and significantly with plasma glucose concentrations (Larsen et al., 2010).”
BackgroundBeyond genetics. Influence of dietary factors and gut microbiota on type 1 diabetes
Nielsen, D. S., Krych, Ł., Buschard, K., Hansen, C. H. F., & Hansen, A. K. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.04.010 · Cited by 75
“Recent years development within mainly high throughput sequencing technologies have enabled hitherto unseen detailed characterization of the human GM establishing links between GM and a range of disease conditions such as type 2 diabetes [101,102] and autoimmune diseases like atopic dermatitis [103].”
Self-citationJayasinghe, T. N., Chiavaroli, V., Holland, D. J., Cutfield, W. S., & O'Sullivan, J. M. (2016) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2016.00015 · Cited by 77
Duncan, K., Carey-Ewend, K., & Vaishnava, S. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1874815 · Cited by 73
“metabolic disorders (55, 56), obesity (57, 58), and inflammatory bowel disease (7), all of which are pathologies characterized by intestinal inflammation (57).”
BackgroundSystematic review of gut microbiota and attention-deficit hyperactivity disorder (ADHD)
Sukmajaya, A. C., Lusida, M. I., Soetjipto, & Setiawati, Y. (2021) · Annals of General Psychiatry · doi:10.1186/s12991-021-00330-w · Cited by 74
“In mice model study, it is found that Allobaculum, Anaeroplasma, and Erwinia genera are more abundant in male mice, while SMB53 genus from Clostridiaceae family and Dorea, Coprococcus, and Ruminococcus genera are more abundant in female mice [16].”
BackgroundInfluentialGut microbiota mediated T cells regulation and autoimmune diseases
Bhutta, N. K., Xu, X., Jian, C., Wang, Y., Liu, Y., Sun, J., Han, B., Wu, S., & Javeed, A. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1477187 · Cited by 83
Han, L., Li, T., Du, ., Chang, R., Zhan, B., & Mao, X. (2019) · Nutrients · doi:10.3390/nu11030670 · Cited by 82
Beneficial microbiota. Probiotics and pharmaceutical products in functional nutrition and medicine
Novik, G., & Savich, V. (2020) · Microbes and Infection · doi:10.1016/j.micinf.2019.06.004 · Cited by 76
Liu, T.-W., Park, Y.-M., Holscher, H. D., Padilla, J., Scroggins, R. J., Welly, R., Britton, S. L., Koch, L. G., Vieira-Potter, V. J., & Swanson, K. S. (2015) · PLOS ONE · doi:10.1371/journal.pone.0136150 · Cited by 78
“However, it agrees with previous research assessing gut microbiota in adult humans with or without type 2 diabetes [36].”
ResultThe salivary microbiome of diabetic and non‐diabetic adults with periodontal disease
Sabharwal, A., Ganley, K., Miecznikowski, J. C., Haase, E. M., Barnes, V. M., & Scannapieco, F. A. (2018) · Journal of Periodontology · doi:10.1002/jper.18-0167 · Cited by 86
“Also, dysbiosis of the gut microbiome has been demonstrated in diabetic patients.(4,14) In their seminal work on gut microbiota in obesity, Turnbaugh et al.”
BackgroundTesei, D., Jewczynko, A., Lynch, A., & Urbaniak, C. (2022) · Life · doi:10.3390/life12040495 · Cited by 88
Cortellini, A., D’Alessio, A., Cleary, S., Buti, S., Bersanelli, M., Bordi, P., Tonini, G., Vincenzi, B., Tucci, M., Russo, A., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-3116 · Cited by 89
Gut microbes in metabolic disturbances. Promising role for therapeutic manipulations?
Portincasa, P., Khalil, M., Graziani, A., Frühbeck, G., Baffy, G., Garruti, G., Ciaula, A. D., & Bonfrate, L. (2023) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2023.10.002 · Cited by 84
Changes in human gut microbiota influenced by probiotic fermented milk ingestion
Unno, T., Choi, J.-H., Hur, H.-G., Sadowsky, M. J., Ahn, Y.-T., Huh, C.-S., Kim, G.-B., & Cha, C.-J. (2015) · Journal of Dairy Science · doi:10.3168/jds.2014-8943 · Cited by 78
“Although colonization in the gut by beneficial microorganisms may have significant effects on human health (Larsen et al., 2010) and may change the metabolic capacity of the gut (Claus et al.”
BackgroundSample preparation optimization in fecal metabolic profiling
Deda, O., Chatziioannou, A. C., Fasoula, S., Palachanis, D., Raikos, Ν., Theodoridis, G. A., & Gika, H. (2016) · Journal of Chromatography B · doi:10.1016/j.jchromb.2016.06.047 · Cited by 84
Hu, X., Liu, G., Shafer, A. B. A., Wei, Y., Zhou, J., Lin, S., Wu, H., Zhou, M., Hu, D., & Liu, S. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00572 · Cited by 87
“, 2010), host diseases (Andersson et al., 2008; Larsen et al., 2010), diet composition (Shanks et al.”
BackgroundPrebiotics in the management of components of the metabolic syndrome
O'Connor, S. E., Chouinard-Castonguay, S., Gagnon, C., & Rudkowska, I. (2017) · Maturitas · doi:10.1016/j.maturitas.2017.07.005 · Cited by 86
Pérez, M. M., Martins, L. M. S., Dias, M. S., Pereira, C. A., Leite, J. A., Gonçalves, E. C. S., de Almeida, P. Z., de Freitas, E. N., Tostes, R. C., Ramos, S. G., et al. (2019) · Immunology · doi:10.1111/imm.13028 · Cited by 73
Depigmentation and Anti-aging Treatment by Natural Molecules
Zaid, A. N., & Al-Ramahi, R. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190703153730 · Cited by 84
Zhao, T., Zhang, H., Yin, X., Zhao, H., Ma, L., Yan, M., Peng, L., Wang, Q., Dong, X., & Li, P. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110325 · Cited by 81
Microbiota Transplant in the Treatment of Obesity and Diabetes: Current and Future Perspectives
Napolitano, M., & Covașă, M. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.590370 · Cited by 84
Umirah, F., Neoh, C. F., Ramasamy, K., & Lim, S. M. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108689 · Cited by 84
Gut Microbiota and Gynecological Cancers: A Summary of Pathogenetic Mechanisms and Future Directions
Borella, F., Carosso, A. R., Cosma, S. D., Preti, M., Collemi, G., Cassoni, P., Bertero, L., & Benedetto, C. (2021) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00839 · Cited by 82
Geographic variation in the eukaryotic virome of human diarrhea
Holtz, L. R., Cao, S., Zhao, G., Bauer, I. K., Denno, D. M., Klein, E. J., Antonio, M., Stine, O. C., Snelling, T., Kirkwood, C. D., et al. (2014) · Virology · doi:10.1016/j.virol.2014.09.012 · Cited by 83
“For example, a dysbiosis or shift in the relative abundances of the bacterial taxa has been associated with obesity (Turnbaugh et al., 2009), inflammatory bowel disease (Frank et al., 2007; Sartor, 2008), diabetes (Larsen et al., 2010), and necrotizing enterocolitis (Mai et al., 2011).”
BackgroundFecal Biomarkers of Intestinal Health and Disease in Children
Pang, T., Leach, S. T., Katz, T., Day, A. S., & Ooi, C. Y. (2014) · Frontiers in Pediatrics · doi:10.3389/fped.2014.00006 · Cited by 83
“There is abundant evidence that dysbiosis may have multiple effects on the physiology and immunology of the host, and has been associated with the development of a variety of diseases including atopy (6), obesity (7), types I and II diabetes (8, 9), cardiovascular disease (10), and inflammatory disorders (11, 12).”
BackgroundTanca, A., Palomba, A., Pisanu, S., Addis, M. F., & Uzzau, S. (2015) · PROTEOMICS · doi:10.1002/pmic.201400573 · Cited by 76
Intestinal microbiota in inflammation and insulin resistance: relevance to humans
Bandt, J. P. D., Waligora‐Dupriet, A., & Butel, M. (2011) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e328347924a · Cited by 86
The Consumption of Bicarbonate-Rich Mineral Water Improves Glycemic Control
Murakami, S., Goto, Y., Ito, K., Hayasaka, S., Kurihara, S., Soga, T., Tomita, M., & Fukuda, S. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/824395 · Cited by 87
Linking microbiota and respiratory disease
Hauptmann, M., & Schaible, U. E. (2016) · FEBS Letters · doi:10.1002/1873-3468.12421 · Cited by 88
Tolerogenic probiotics: potential immunoregulators in Systemic Lupus Erythematosus
Esmaeili, S., Mahmoudi, M., Momtazi‐Borojeni, A. A., Sahebkar, A., Doulabi, H., & Rastin, M. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25748 · Cited by 80
“…(Apperloo-Renkema, Bootsma, Mulder, Kallenberg, & Van Der Waaij, 1994; Frank et al., 2007; Garrett et al., 2010; Hevia et al., 2014; Holler, Landfried, Meier, Hausmann, & Rogler, 2010; Larsen et al., 2010; López et al., 2016; Wen et al., 2008; Yeoh, Burton, Suppiah, Reid, & Stebbings, 2013).”
Intestinal AMPK modulation of microbiota mediates crosstalk with brown fat to control thermogenesis
Zhang, E., Jin, L., Wang, Y., Tu, J., Zheng, R., Ding, L., Fang, Z., Fan, M., Al-Abdullah, I., Natarajan, R., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28743-5 · Cited by 76
Videnska, P., Smerkova, K., Zwinsova, B., Popovici, V., Micenkova, L., Sedlar, K., & Budinska, E. (2019) · Scientific Reports · doi:10.1038/s41598-019-49520-3 · Cited by 72
Cornuault, J. K., Moncaut, E., Loux, V., Mathieu, A., Sokol, H., Petit, M., & Paepe, M. D. (2019) · The ISME Journal · doi:10.1038/s41396-019-0566-x · Cited by 79
Peiseler, M., & Tacke, F. (2021) · Cancers · doi:10.3390/cancers13040730 · Cited by 71
Jiang, H., Zhang, Y., Xu, D., & Wang, Q. (2021) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23650 · Cited by 82
Berberine: Pharmacological Features in Health, Disease and Aging
Gasmi, A., Asghar, F., Zafar, S., Oliinyk, P., Khavrona, O. P., Lysiuk, R., Peana, M., Piscopo, S., Antonyak, H., Pen, J. J., et al. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867330666230207112539 · Cited by 83
The F/B ratio as a biomarker for inflammation in COVID-19 and T2D: Impact of metformin
Petakh, P., Oksenych, V., & Kamyshnyi, O. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114892 · Cited by 81
“Specifically, T2D patients have been found to have a lower relative abundance of Firmicutes and a higher proportion of Bacteroidetes and Proteobacteria compared to non-diabetic individuals [18].”
BackgroundSasaki, M., Ogasawara, N., Funaki, Y., Mizuno, M., Iida, A., Goto, C., Koikeda, S., Kasugai, K., & Joh, T. (2013) · BMC Gastroenterology · doi:10.1186/1471-230x-13-81 · Cited by 76
“Recently, the risk factors for T2DM was observed to involve other genomes; hence, a metagenome-wide association study should also be performed to analyze intestinal microbiota content [12].”
BackgroundManiar, K., Moideen, A., Mittal, A., Patil, A., Chakrabarti, A., & Banerjee, D. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.12.003 · Cited by 77
“Diabetic patients show a reduced diversity and distinct composition of gut microbiota compared to controls[89].”
BackgroundCore gut microbiota in Jinhua pigs and its correlation with strain, farm and weaning age
Yang, H., Xiao, Y., Wang, J., Xiang, Y., Gong, Y., Wen, X., & Li, D. (2018) · The Journal of Microbiology · doi:10.1007/s12275-018-7486-8 · Cited by 83
Ganci, M., Suleyman, E., Butt, H., & Ball, M. (2019) · Brain and Behavior · doi:10.1002/brb3.1408 · Cited by 83
“…Nelson, & Palombo, 2008), anxiety (Burch, 2016), depression (e.g., Jiang et al., 2015), obesity (Ley, Turnbaugh, Klein, & Gordon, 2006), diabetes (Larsen et al., 2010), coronary ar‐ tery disease (Cui, Zhao, Hu, Zhang, & Hua, 2017; Emoto et al., 2017), and cancer (particularly colorectal…”
Bataineh, M. T. A., Dash, N. R., Lassen, P. B., Banimfreg, B. H., Nada, A. M., Belda, E., & Clément, K. (2020) · Scientific Reports · doi:10.1038/s41598-020-66598-2 · Cited by 84
Wang, T., Zhang, X., Chen, A., Zhang, J., Lv, B., Ma, M.-H., Lian, J., Wu, Y., Zhou, Y.-T., Ma, C., et al. (2020) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-020-10689-7 · Cited by 79
Soy bioactive peptides and the gut microbiota modulation
Ashaolu, T. J. (2020) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-020-10799-2 · Cited by 82
“Sample clinical studies reported on patients with inflammatory bowel disease (IBD) and type 2 diabetes showed both groups to have fewer Bacteroidetes and Firmicutes, and Firmicutes phyla members in their gut, respectively (Larsen et al. 2010; Peterson et al. 2008).”
BackgroundArcher, A. C., Peddha, M. S., & Halami, P. M. (2021) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-021-09744-0 · Cited by 80
Zhao, J., Li, Y., Sun, M., Yu, C., Li, J.-Y., Wang, S.-H., Yang, D., Guo, C., Du, X., Zhang, W., et al. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i8.708 · Cited by 81
Shang, J., Liu, F., Zhang, B., Dong, K., Lu, M., Jiang, R., Xu, Y., Diao, L., Zhao, J., & Tang, H. (2021) · PeerJ · doi:10.7717/peerj.11128 · Cited by 73
“A previous study reported that Bacteroidetes and Proteobacteria, could produce LPS, and subsequently trigger inflammatory response and contribute to the development of diabetes (Larsen et al., 2010).”
BackgroundZhu, J., Wu, M., Zhou, H. J., Cheng, L., Wei, X., & Wang, Y. (2021) · Food Research International · doi:10.1016/j.foodres.2021.110594 · Cited by 80
Gut Microbiota and Subclinical Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus
Tsai, H.-J., Tsai, W., Hung, W., Hung, W., Chang, C.-C., Dai, C., & Tsai, Y. (2021) · Nutrients · doi:10.3390/nu13082679 · Cited by 81
“However, the proportion of the phylum Firmicutes is significantly lower in T2D patients compared to healthy individuals, and the phyla Firmicutes-to-Bacteroidetes ratio (F/B ratio) has been significantly associated with impaired glucose metabolism [11].”
BackgroundGabarre, P., Loens, C., Tamzali, Y., Barrou, B., Jaisser, F., & Tourret, J. (2021) · American Journal of Transplantation · doi:10.1111/ajt.16836 · Cited by 85
Modulation of gut microbiota by bioactive compounds for prevention and management of type 2 diabetes
Sharma, B. R., Jaiswal, S., & Veeranna, R. P. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113148 · Cited by 80
Zhou, X., Kong, X., Lian, G., Blachier, F., Geng, M., & Yin, Y. (2014) · Nutrition Research · doi:10.1016/j.nutres.2014.08.008 · Cited by 77
— Invited Review — Metagenomic investigation of gastrointestinal microbiome in cattle
Kim, M., Park, T., & Yu, Z. (2017) · Asian-Australasian Journal of Animal Sciences · doi:10.5713/ajas.17.0544 · Cited by 84
“Prevotella CACCAAGGCGACGATCA GGATAACGCCYGGACCT 60 283 [119]”
Adachi, K., Sugiyama, T., Yamaguchi, Y., Tamura, Y., Izawa, S., Hijikata, Y., Ebi, M., Funaki, Y., Ogasawara, N., Goto, C., et al. (2019) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.18-101 · Cited by 70
Lee, C. J., Florea, L., Sears, C. L., Maruthur, N. M., Potter, J. J., Schweitzer, M., Magnuson, T. H., & Clark, J. M. (2019) · Obesity Surgery · doi:10.1007/s11695-019-03976-4 · Cited by 81
Altered Metabolome of Lipids and Amino Acids Species: A Source of Early Signature Biomarkers of T2DM
Hameed, A., Mojsak, P., Buczyńska, A., Suleria, H. A. R., Kretowski, A. J., & Ciborowski, M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9072257 · Cited by 89
Zhang, T., Zhao, W., Xie, B., & Liu, H. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.104038 · Cited by 75
Cui, H.-X., Hu, Y.-N., Li, J.-W., & Yuan, K. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/8930374 · Cited by 74
Petersen, C., Wankhade, U. D., Bharat, D., Wong, K., Mueller, J. E., Chintapalli, S. V., Piccolo, B. D., Jalili, T., Jia, Z., Symons, J. D., et al. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.01.004 · Cited by 73
“This is consistent with previous studies that showed the compositional changes in gut microbiota at phylum and genus levels in both type 1 and type 2 diabetes [37], [38], [39].”
BackgroundResultThe oral microbiome profile and biomarker in Chinese type 2 diabetes mellitus patients
Chen, B., Wang, Z., Wang, J., Su, X., Yang, J., Zhang, Q., & Zhang, L. (2020) · Endocrine · doi:10.1007/s12020-020-02269-6 · Cited by 82
Breast Cancer: Lifestyle, the Human Gut Microbiota/Microbiome, and Survivorship
Bodai, B. I., & Nakata, T. E. (2020) · The Permanente Journal · doi:10.7812/tpp/19.129 · Cited by 74
Investigation of Spaceflight Induced Changes to Astronaut Microbiomes
Morrison, M. D., Thissen, J. B., Karouia, F., Mehta, S. K., Urbaniak, C., Venkateswaran, K. J., Smith, D. J., & Jaing, C. J. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.659179 · Cited by 80
Diabetes-related alterations in the enteric nervous system and its microenvironment
Bagyánszki, M. (2012) · World Journal of Diabetes · doi:10.4239/wjd.v3.i5.80 · Cited by 71
Gut microbiota imbalances in Tunisian participants with type 1 and type 2 diabetes mellitus
Fassatoui, M., López‐Siles, M., Díaz‐Rizzolo, D. A., Jmel, H., Naouali, C., Abdessalem, G., Chikhaoui, A., Nadal, B., Jamoussi, H., Abid, A., et al. (2019) · Bioscience Reports · doi:10.1042/bsr20182348 · Cited by 73
Yang, Y., Shi, Y., Wiklund, P., Tan, X., Wu, N., Zhang, X., Tikkanen, O., Zhang, C., Munukka, E., & Cheng, S. (2017) · Nutrients · doi:10.3390/nu9080792 · Cited by 72
“Gut microbial imbalance, followed by a state of dysbiosis, in turn, is associated with obesity [3], type 2 diabetes [4], cardiovascular disease [5] and non-alcoholic fatty liver disease [6].”
BackgroundGut microbiota composition and frailty in elderly patients with Chronic Kidney Disease
Margiotta, E., Miragoli, F., Callegari, M. L., Vettoretti, S., Caldiroli, L., Meneghini, M., Zanoni, F., & Messa, P. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228530 · Cited by 80
“and Prevotella-Bacteroides group quantification was performed as described by Larsen et al [23].”
MethodZeng, Z., Guo, X., Zhang, J., Yuan, Q., & Chen, S. (2021) · Food & Function · doi:10.1039/d1fo00515d · Cited by 80
Xu, Q., Su, Z., Yang, W., Zhong, M., Xian, Y., & Lin, Z. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02704-1 · Cited by 79
“Moreover, a reduction in Firmicutes has also been found in patients with type 2 diabetes mellitus (T2DM) and individuals with obesity [89, 90].”
BackgroundLarsen, N., Vogensen, F. K., Gøbel, R., Michaelsen, K. F., Al-Soud, W. A., Sørensen, S. J., Hansen, L. H., & Jakobsen, M. (2011) · FEMS Microbiology Ecology · doi:10.1111/j.1574-6941.2010.01024.x · Cited by 74
Self-citationGastrointestinal Microbiota and Metabolite Biomarkers in Children With Autism Spectrum Disorders
Wang, L., Conlon, M. A., Christophersen, C. T., Sorich, M. J., & Angley, M. T. (2014) · Biomarkers in Medicine · doi:10.2217/bmm.14.12 · Cited by 70
Metadata
- Authors
- Larsen, N., Vogensen, F. K., van den Berg, F. W. J., Nielsen, D. S., Andreasen, A. S., Pedersen, B. K., Al-Soud, W. A., Sørensen, S. J., Hansen, L. H., & Jakobsen, M.
- Affiliations
- University of Copenhagen (DK)
- Rigshospitalet (DK)
- Corresponding author
- Larsen, Nadja
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-02-05
- Volume
- 5
- Issue
- 2
- Pages
- e9085
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2816710
- OpenAlex
- W2135989088
- Cited by
- 2,952
- References
- 38
- Citations by year
- 2026: 90 · 2025: 168 · 2024: 217 · 2023: 199 · 2022: 296 · 2021: 331 · 2020: 294 · 2019: 264 · 2018: 191 · 2017: 158 · 2016: 174 · 2015: 150 · 2014: 134 · 2013: 115 · 2012: 83
- FWCI
- 36.90
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Ministeriet for Fø devarer, Landbrug og Fiskeri
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- type 2 diabetes, gut microbiota, Firmicutes, Bacteroidetes, Betaproteobacteria, plasma glucose, glucose tolerance, obesity, metabolic disorders, 16S rRNA gene
- MeSH terms
- Adult, Aged, Bacteria, Diabetes Mellitus, Type 2, DNA, Bacterial, Feces, Humans, Intestines, Male, Middle Aged, RNA, Ribosomal, 16S, Colony Count, Microbial, Body Mass Index, Sequence Analysis, DNA
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.